Veru Inc. is an oncology and urology biopharmaceutical company developing and commercializing novel medicines for the prostate cancer continuum of care and urology specialty pharmaceuticals.
August 8, 2019
Listen to the replay of our latest earnings conference call.
Listen to other presentations and conference calls
June 4, 2019
Watch the replay of the webcast of our presentation at the Jefferies 2019 Healthcare Conference.
(View Slide Deck)
We’re looking forward to presenting at the upcoming 2018 Jefferies Healthcare Conference Presentation. As soon as the conference starts, the link will be available. See you there!
Veru Reports Higher Net Revenues and Gross Profit for its Fiscal 2019 Third Quarter
August 1, 2019
Veru to Report Fiscal 2019 Third-Quarter Financial Results; Host Conference Call on August 8th